XML 32 R13.htm IDEA: XBRL DOCUMENT v3.24.3
RESTRUCTURING
 12 Months Ended
Sep. 27, 2024
Restructuring and Related Activities [Abstract]  
RESTRUCTURING RESTRUCTURING
    In July 2018, the Company committed to relocate the production of amorphous silicon glass for digital detectors from its Santa Clara facility to the dpiX fabrication facility in Colorado. In July 2019, the Company committed to close its Santa Clara facility and to relocate the remaining production to its other existing facilities. The Company ceased all operations at the Santa Clara facility as of October 2, 2020, and all activities related to the closure of the facility were completed by the end of December 2020.
    Cash outflows associated with these restructuring charges are limited to employee termination expenses, facility closure and equipment sales and disposals. Below is a detail of restructuring charges incurred during the 2024, 2023 and 2022 fiscal years, which predominately relate to the Company's Medical segment:
(In millions)Location of Restructuring Charges in Consolidated Statements of Operations202420232022
Other assets impairment chargesSelling, general and administrative$— $— $1.8